Internal Medicine, Pulmonary Disease · Sacramento, CA
NPI
1649254467
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4150 V St, Suite 3400
Sacramento, CA, 95817
Phone (916) 734-3564
Groups this clinician bills Medicare through
Medicare paid, 2024
$74K
1,223 services
Medicare patients, 2024
385
Average age 71
Drug cost, 2024
$11.5M
2,458 prescriptions
Company payments, 2025
$14K
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark V Avdalovic was code 99214 (office e&m - established), 364 times for 178 patients. In total Mark V Avdalovic billed 1,223 services in 39 codes, and Medicare paid $74K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-09-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 364 | 178 | $85.75 | $31K |
| 99213 Office E&M - Established | Office | 127 | 97 | $55.16 | $7,006 |
| 99232 Hospital E&M - Subsequent | Facility | 118 | 33 | $61.97 | $7,313 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 91 | 71 | $13.27 | $1,208 |
| 94729 Pulmonary Function Testing | Office | 53 | 53 | $19.93 | $1,056 |
| 94726 Pulmonary Function Testing | Office | 52 | 52 | $20.44 | $1,063 |
| 94729 Pulmonary Function Testing | Facility | 37 | 37 | $7.08 | $262 |
| 99215 Office E&M - Established | Office | 35 | 27 | $114.59 | $4,010 |
| 94726 Pulmonary Function Testing | Facility | 34 | 34 | $9.57 | $325 |
| 94010 Pulmonary Function Testing | Office | 33 | 33 | $12.11 | $400 |
| 99291 Critical Care E&M | Facility | 32 | 12 | $168.55 | $5,394 |
| 99205 Office E&M - New | Office | 27 | 27 | $146.54 | $3,957 |
| 99222 Hospital E&M - Initial | Facility | 25 | 24 | $104.85 | $2,621 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 21 | 18 | $25.40 | $533 |
| 94060 Pulmonary Function Testing | Office | 20 | 20 | $9.57 | $191 |
By year: 2022 $74K for 1,316 services; 2023 $70K for 1,083 services; 2024 $74K for 1,223 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark V Avdalovic prescribed most often to Medicare patients was Ambrisentan, with 219 prescriptions and refills. In total Mark V Avdalovic wrote 2,458 Medicare prescriptions that cost $11.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ambrisentan Generic | 219 | 235 | 26 | $840K |
| Adempas Riociguat | 211 | 211 | 23 | $2.9M |
| Tadalafil Generic | 201 | 309 | 33 | $187K |
| Furosemide Generic | 182 | 340 | 49 | $1,113 |
| Spironolactone Generic | 134 | 283 | 32 | $2,015 |
| Opsumit Macitentan | 102 | 106 | 11 | $1.3M |
| Orenitram Er Treprostinil Diolamine | 80 | 86 | Under 11 | $854K |
| Tyvaso Dpi Treprostinil | 78 | 78 | Under 11 | $1.8M |
| Bumetanide Generic | 75 | 141 | 15 | $5,136 |
| Letairis Ambrisentan | 72 | 92 | 13 | $1.1M |
| Potassium Chloride Generic | 72 | 113 | 15 | $1,941 |
| Sildenafil Citrate Generic | 70 | 107 | 16 | $7,676 |
| Eliquis Apixaban | 56 | 94 | 11 | $53K |
| Uptravi Selexipag | 52 | 52 | Under 11 | $1.4M |
| Albuterol Sulfate Hfa Albuterol Sulfate | 49 | 60 | Under 11 | $1,642 |
Brand drugs: - claims; generic drugs: 1,387 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark V Avdalovic $14K ($14K in general payments such as food, travel and fees) from 3 companies. The largest payer was United Therapeutics Corporation with $8,287.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.